Eli Lilly and Company vs JPMorgan Chase & Co.
Eli Lilly and Company is worth $1.061T, 1.1× the $947.643B market cap of JPMorgan Chase & Co.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $947.643B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $356.50 |
| Change | -2.11% | -1.53% |
| Revenue | $65.179B | $181.847B |
| Net income | $20.640B | $57.048B |
| Country | United States | United States |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than JPMorgan Chase & Co.?
- Eli Lilly and Company has a market cap of $1.061T against $947.643B for JPMorgan Chase & Co., making it 1.1 times as valuable.
- Which company earns more, LLY or JPM?
- Eli Lilly and Company reported net income of $20.640B and JPMorgan Chase & Co. reported $57.048B in their most recent annual periods.